chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint pains; muscle pains; Weakness in joints and muscle; Weakness in joints and muscle; This is a spontaneous report from a contactable consumer (patient herself). A 56-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Left on 10Mar2021 at 14:30 (at the age of 56-year-old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies as yes. No concomitant medications reported. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks prior to the COVID vaccine. The patient was not having COVID prior vaccination and has not been COVID tested post vaccination. On 12Mar2021, the patient experienced Joint pains, muscle pains, Weakness in joints and muscle. The patient did not receive any treatment for the adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
PARENT LIED ABOUT CHILDS AGE TO GET BOOSTER SHOT. SHE WAS 6 DAYS SHY OF TURNING 12 YRS OF AGE.
Info has been received from a health professional concerning a female, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Throat closed, pain throat area, gagging cough, injection site tender but not red. Lasted approx 2 hour then started to resolve. Neck & shoulder pain last several more hours.
I was very sick and had abdominal pain on the right with vomiting one month after the second dose of the vaccine. I went to Urgent care and I was sent home. It was bad pain and it reoccurred. I have had the Shingles vaccine and I had the Shingles, and I was given medication because I had the Shingles. It was an Anti-viral which I took for ten days. Two weeks later I had a temperature of 103 and abdominal pain. I was admitted on 05/24/2021 and I had my Gall Bladder removed and the Gallstones removed the next day. I have had Gallstones for years, but I have not had problems.
Injection site itching; Hard (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE INDURATION (Hard (Injection Site)) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE INDURATION (Hard (Injection Site)). At the time of the report, VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE INDURATION (Hard (Injection Site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Got the vaccine, still got it/suspected vaccination failure; Still got it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingrix.     Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the vaccine and still got them. The patient stated that not as bad. The patient stated that get the vaccine or it will be worse. The reporter did not consent to follow-up. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Approx 24 hrs p/vax developed flu-like sx, n, tiredness, chills, legs limp x 2 days; To ER; vax site redness, & soreness; Feels like can't breath, something on chest;
Rapid heart beat, tingling lips, sensation of throat closing, hard to swallow, body trembling, i felt cold, hands were cold and my face was a little red. Blood pressure and pulse ox taken twice. 159/57 (not my normal). Was given several bottles of water and cookies. Was observed for approx. 45mins. Symptoms slowly got better. Was told ok to leave and that i should take some benedryl after i left. Developed some hives on my chest and neck after I left the facility. Took benedryl as instructed. Hives went away. Throat still feels a little swollen.
I experienced extreme pain in my hip after receiving the vaccine and pain was even worse; therefore, I went to urgent care on 10/25/2021 The doctor did an X-ray and said that I had bad arthritis in my hip (received an injection for inflammation) along with a meloxicam 7.5 mg to take for the pain. I am awaiting an appointment to see an Orthopedic Specialist (referred by urgent care center). The symptoms are better since I have been taking the medication but are continuing to cause issues for me.
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 24-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 144 hours and then at 33 Fahrenheit (F) Degrees (0.555555556 Celsius) for a total of 72 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 11:48 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 12:01 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Mar-2021 at 11:48 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 68.60   Concomitant products were not provided  On 02-MAR-2021, Excursion time was 09 AM,10 AM, 11 AM, 12PM, 2PM, 3PM, temperature was 33,35,35,35,35,34,34,35 total doses given for the day was 177, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Feb-2021, vial was moved to clinic on 02-Mar-2021. 16 vials were sent to clinic. Vaccine BUD date was 26-Mar-2021.   On 02-MAR-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 27, 10 AM: 29, 11 AM: 32, 12 AM: 33, 1PM: 36, 2 PM: 35, 3 PM: 36, 4 PM: 37 and 5 PM: 37  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.   Temperature recordings were taken using a traceable temperature monitor at every hour.    After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.   It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.   Treatment medications were not reported.
chills, temperature of 99.6, bone pain of long bones and back and neck, fatigue, mild headache
Fever & h/a since since 24hr p/shots; States has never had h/a like this before; Referred to MD for further assessment;
fixed drug reaction; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (fixed drug reaction) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (fixed drug reaction). At the time of the report, VACCINATION COMPLICATION (fixed drug reaction) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was unknown by the reporter. Treatment information was not provided. Reporter stated that he want to consider whether there were ingredients common to moderna covid and shigrix vaccinations so as to avoid further significant vaccine reactions.  The patient had fixed drug reaction at second vaccination site on deltoid. There was tumid, erythematous to violet and hyperpigmented large plaque on deltoid with distant lesions featuring hyperpigmentation present on arms. The patient stated that the adverse event was most likely caused by vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Additional information received on 27-Jul-2021.Updated reporter information; added patient details and event details.
States had felt her heart beating fast, had a swollen tongue and a weird feeling. PHN checked BP and was 142/84, pulse 94 apically, O2 sats 94% on RA. Patient stated that the feeling lasted for just a minute. PHN gave juice to patient after checking vitals and she stated she felt much better.  Asked if would like some Benadryl and she said she took an allergy medication this morning as part of her normal routine. Patient also stated she has a history of an irregular heart rhythm. She stated she ate well for breakfast this morning to ensure she did not have a low blood sugar while waiting for her shot. Note time of incidence at 1139am and had not eaten since breakfast. Patient stated she was fine to go home after her 30 minute wait time. Her VS were good at this time. PHN requested that patient contact her PCP if there were any further concerns following her leaving the site for the vaccination.
Within an hour I was light headed, followed by extreme aches and fever, then chills. Unable to get out of bed. 60 hours duration.
This spontaneous report as received from a pharmacist refers to the pharmacist's 4 year old male patient. On an unknown date the patient was vaccinated with the second dose of VARIVAX (Merck) (lot # was not reported). On an unknown date the patient experienced rash at unspecified location. It was not reported whether the patient medical attention. The outcome of rash at unspecified location was reported as recovered/resolved on an unknown date. Additional information is not expected.
Starting 01/04/2022, I did not know I had been exposed but I woke up with a very dry mouth and had a very bad headache. I couldn't sleep well because my head was killing me. The headache lasted for 12 hours and I called out of work. I kept hydrating and the headache eventually went away, but the dry mouth continued. Then, the next day I had sneezing and running nose (constantly). The next day I kept sneezing more. I was informed by a friend that she tested positive for COVID and I had gone to dinner with her a few days prior. I got tested for COVID and it was positive. I had mild symptoms and I feel the vaccine really helped.
Started having flu-like symptoms (chills, tenderness, fever, tiredness) 10 hours after vaccine.  Took some Tylenol and later Ibuprofen that helped these symptoms.  Then started getting hives on my forearms 20 hours after vaccine.  Also noticed my heart rate was rapid (110 - 140 bpm).  I took some a dose of benadryl, and that seemed to get rid of the hives, but heart rate was still elevated.  I scheduled an appointment at urgent care center and was seen by a doctor 25 hours after vaccine.  Hives had returned, along with a little tightness in chest.  Doctor prescribed prednisone and epipen.  Picked those up at pharmacy 27 hours after vaccine and started prednisone right away, along with another dose of benadryl.  Hives slowly diminished, but was extremely exhausted.  Slept well, and am now continuing prednisone as directed along with a daily Zyrtec.  Never used epipen.
Pt had flu shot - felt fine. Mowed grass came in and felt tight in chest, difficulty with shortness of breath, hard time talking. If she over exerts- sx return. Took Aspirin-helped tightness.
Pt telephoned on 03/20/2002 at 11am stating that on 03/16/2002 at around 11:30 am, she noted rash at injection site of left arm, swelling and immobility of left arm for 2-3 days. Pt also states she is experinecing cold like symptoms (sneezing and coughing).
2:20 A little nervous prior to inj. after received inj. not, nausea, faint, bent over eased self to floor, ice pack to underarm - ammonia inh. to nostril.
Patient received Janssen vaccine on 5/14/21 around 3:35pm. After receiving her vaccine, she did not remain seated and fell to the floor immediately upon standing. She was unconscious but still breathing and regained consciousness about 30-45 seconds after her partner and I went to her. She was alert and was able to question what happened. She said she felt "tingly" and nothing else. She remained on the floor until EMT arrived. She was taken to a local hospital after vitals were taken by EMT unit.
Patient started itching and having swelling to her left deltoid approximately 30 minutes after injection.  Cold compress was immediately put to area. Patient then started to have continued redness down into L) arm past elbow, down armpit, into L) side of abdomen, up into L) side of neck up into L) side of face and L) ear lobe.  Patient was seen at approximately 5:00pm pm by a physician and was told to take prednisone and Zytrec.  Patient went home and by 5:45pm patient has swelling in left elbow the size of a baseball.  Patient took prednisone 20mg and Zytrec at 5:45pm, continued to have swelling, itching, numbness/tingling and c/o scratchy throat.  Patient denied any SOB.  Patient continued to have s/s through the night and this am at 10am patient still continues to have itch and golf ball sized edema around injection site.
Passed out twice twelve hours after vaccination. Lost vision entirely for several minutes. Began to lose hearing. Severe sweating; elevated heart rate. Nausea.
Patient started feeling flu-like symptoms within hours of receiving the vaccination. Within 12 hours, patient had a low grade fever and within 48 hours, patient had a fever of 101.5. Fever fell back to low grade after 72 hours but aches and low grade fever persisted for 12 days.
Patient called and advised she is itchy and began to have a rash that emanated from her right shoulder today after vaccine injections and has begun to spread to her abdomen and face. Patient was advised to go to the nearest emergency department and to call 911 if she began to have any trouble breathing, which she denied at the time of the call. Speaking in full sentences and without any distress in her voice. Patient went to the ED twice. The first time she received an EPIPEN injection, went home and her lips began to swell so she went back and received a BENADRYL injection, and is resting at home on steroids and oral BENADRYL now.
Pt reports that immediately after receiving pfizer covid vaccine, she began to feel like her tongue was swelling. She was given liquid benadryl. No rash/hives/lip swelling/eyelid swelling/diarrhea.  Similar feeling w eating scallops, but also never had swollen lips/rash.  Denies voice change/wheezing/sob/cough.
12Mar90 pt vax;  17Jun90 devel polyarthritis esp in hands.  Seen by MD who felt that sx were not related to vax.
1 1/2cm of erythema surrounding injection site for 36 hours post injection.
Varivax 05/13/1999 lot # 245311. Developed Chicken pox- less than 50 lesions by eyes and trunk.
Muscle soreness and a ?catching? in the muscle when arm is lifted that has lasted 3 weeks. Pain is severe enough to interfere with sleeping
Pt recvd vax & exp weakness, vertigo & sx similar to MS; no treatment was given; 23SEP92 sx persist;
Received the first Shingrix shot over a year ago; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose over a year ago before the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was self reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter reported that if he/she received the first Shingrix shot over a year ago, should he/she get the second. Follow up would not be possible, as contact details were not provided.
This spontaneous report was received from an office manager refers to a 4 or 5 months old patient of unknown gender. On 18-MAR-2013, the patient was vaccinated with MMR II (dose, route and lot not reported). Other suspect therapies included VARIVAX (Merck) (dose, route and lot not reported). The office manager reported that the patient who was 4 or 5 months of age received a dose of MMR II and VARIVAX (Merck). No symptoms reported. Additional information has been requested.
couldn't do much of anything; fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MOBILITY DECREASED (couldn't do much of anything) and PYREXIA (fever) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Nasal allergy and Skin cancer. Concomitant products included METOPROLOL, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN 81), FISH OIL, MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS and CREATININE for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (couldn't do much of anything) and PYREXIA (fever). At the time of the report, MOBILITY DECREASED (couldn't do much of anything) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications also included Create (D).  No treatment medications were reported.   This case was linked to MOD-2022-580265, MOD-2022-580266, MOD-2022-580267 (Patient Link).
A nurse reported the occurrence of hives in a 5-year-old male who was vaccinated with diptheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The reporter submitted a report directly to VAERS (local state department reference number C002-026).  The subject had no medical history or concurrent conditions.  He experienced no adverse events following previous immunizations.  Concurrent medications were not specified.  On 08/26/2002, the subject received his fifth injection of Infanrix (lot DTPA541A9).  On 08/28/2002 he developed an injection site reaction characterized by swelling and a 6.5cm - 7cm area of redness and induration.  Additionally, he developed hives on his back.  The reporter stated that the events were possibly related to Infanrix administration.  As of 09/30/2002, the outcome of the events were unknown.
Pt vac w/ flu vac developed weakness and mild numbness in torso lasting seven days. Denies difficulty breathing has not had prior reactions to Flu vaccine. 14Feb91:  Neurologist comment," insufficient evidence to relate sx to flu shot".
Cellulitis with redness, swelling and pain to touch; induration of 1 cm at injection site SC left upper outer arm; redness, swelling and pain started left upper arm. Cellulitis migrated to left elbow and left forearm, with pain by 2/6/16, with resolution of left upper arm redness and swelling. By 2/8/16 still with redness, slight swelling and pain left elbow and left forearm.
Patient has had pain in his shoulder/arm since the shot was given. It does not seem to be getting better.
Extreme nausea,  vomiting, diarrhea,  chills, temperature,  body aches, neck pain, headaches, lowered pulse. They lasted 4 days.
I broke out in hives (not itching) the day after my shot. They went away the next morning. Now I am breaking out in hives daily and they have started just on my arms and hands and have begun to include my feet , legs and stomach and have begun to itch as well. They go away overnight with benadryl.
Pt reports her arm became sore shortly after vaccine and remains sore now (10 days later).
About 12 hours later severe arm pain, extremely fatigue. Diagnosed with Cancer, Carcinoid Tumor on 01/24/22. June '21 went to doctor  had colonoscopy and endoscopy.
Within Minutes of the injection, my tongue went numb and swelled on the right side and I developed hives on my neck and chest. I was instructed to wait 45 minutes past the vaccination time while I was observed by the nurse on-site. I took half of Benadryl. After 40 minutes, the hives had mostly gone away. The tongue numbness and swelling took approx. 4 hours from the injection time to subside.
Blood clot in a superficial vein in the left calf. Symptoms started at end of March/April after the second shot, was initially diagnosed as Baker's Cyst/swelling from running. When I was still having issues in July, I was advised to have it evaluated. Finally did so on Aug 6 and the clot was found. No prior history. Distance runner.
Pain around injection site x 5 days; resolved. Bruising around injection site x15 days; still present.  Redness, warm to touch and mild itching around injeciton site x15 days; still present.